Sambucus Black Elderberry 1000 mg

Sambucus Black Elderberry 1000 mg

Nature's Truth4.7 (32,987 ratings)
Format:Capsule Quantity: 100 Capsule(s) · 100 servings
Goals
$9.97 $0.09 per serving

Product analysis

52 out of 100

Sambucus Black Elderberry 1000 mg is a focused elderberry supplement intended for immune support. Benefits remain uncertain because results vary with the preparation and pattern of use.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality20

The elderberry preparation is unspecified, making quality comparisons difficult. Different preparations cannot be assumed to provide the same effects.

Ingredient Transparency63

The elderberry amount is stated, so the serving size can be checked. The missing preparation details make it harder to compare with a specific extract.

Value For Money40

The elderberry's value for money is uncertain. A meaningful comparison needs its serving cost alongside clear preparation and amount details.

Customer Satisfaction92

Customers report high satisfaction across a very large review base. Widespread buyer approval does not establish immune effectiveness.

Product Focus80

The formula stays focused on elderberry and immune support. Evidence varies by preparation and does not establish a routine adult immune benefit from this serving.

Format
Capsule
Container
100 Capsule(s)
Per serving
$0.09
Customer rating
4.7 · 32,987 ratings
Report analysis

Goals

Immunity
Impact
Highest effect
A+ Ingredient FitD+ PathwaysB+ EvidenceA+ Formulation Logic
European Elder · 1000 mg

European elder is the relevant ingredient, but respiratory findings are mixed and depend on the particular preparation and regimen. The saved findings assign it a contribution, while the supplied scientific context does not establish a generic routine adult immune benefit from this serving.

How this product is rated for Immunity

Ingredient fit100

The formula has a relevant ingredient in the saved findings, but its scientific limitations restrict expectations for routine adult immunity.
Goal fit
The relevant ingredients dominate this formula, although focus alone does not establish a clinical benefit.
Dose adequacy
The declared serving reaches the saved amount comparison; that comparison is not a proven optimal immune dose.

Pathways51

The strongest assigned area is barrier and antimicrobial defense. These ingredient associations do not establish how much infection risk changes.
Depth
The saved findings emphasize barrier and antimicrobial defense; this describes the assigned ingredient roles rather than proven protection against infection.
Breadth
Coverage is concentrated in one immune area, with limited coverage elsewhere.

Evidence80

The saved evidence finding is positive, but the supplied scientific context limits transfer to routine use in general adults.
Evidence strength
European Elder leads the saved evidence finding, but the supplied population and regimen limits prevent a routine adult infection-protection claim.
Studied preparation
The saved preparation finding is complete for the included ingredients; it does not establish that this whole product reproduces a clinical regimen.

Formulation logic100

The included ingredients have no missing required partners or configured conflicts. Meeting the saved amount comparisons does not prove a combined clinical benefit.
Partner coverage
No missing required partner limits the included ingredients in the saved findings; this does not demonstrate an added benefit from combining them.
Conflicts
No configured ingredient conflict was identified. This finding does not establish overall safety or cover every possible interaction.
Effective doses
The included ingredients reach the saved minimum amount threshold; this threshold is not proof of a clinically effective immune dose.
Study evidence

Ingredients

IngredientAmount per servingScore
Sambucus Black Elderberry
1000 mg 100
Gluten Free Adults 18–50 Dairy Free Women
Report overview
A+ Composition And Label DisclosureA+ Composition And Label Disclosure
A serving provides 15.625 mg of Sambucus nigra fruit extract. The saved details identify the species and fruit used in the extract.
How this ingredient is rated

Composition and Label Disclosure100

The saved details identify the species and fruit used in the extract.
Botanical Identity Detail
The saved details identify the species and fruit used in the extract.

Composition and Label Disclosure100

The saved preparation amount is 15.625 mg per serving.
Actual Preparation Amount Disclosure
The saved preparation amount is 15.625 mg per serving.

Commercial Price and Usability

No price or usability rule was evaluated.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Elderberry for prevention and treatment of viral respiratory illnesses: a systematic review.
    Wieland LS; Piechotta V; Feinberg T; Ludeman E; Hutton B; Kanji S; Seely D; Garritty C · BMC complementary medicine and therapies · 2021
    Systematic review5 studies pooledImmunity forEuropean Elder
  2. Select Dietary Supplement Ingredients for Preserving and Protecting the Immune System in Healthy Individuals: A Systematic Review.
    Crawford C; Brown LL; Costello RB; Deuster PA · Nutrients · 2022
    Systematic review39 studies pooledImmunity forEuropean Elder
  3. Black elderberry (Sambucus nigra) supplementation effectively treats upper respiratory symptoms: A meta-analysis of randomized, controlled clinical trials
    Jessie Hawkins, Christy Baker, Lindsey Cherry, Erich Dunne · Complementary Therapies in Medicine · 2019
    Meta-analysis180 participants4 studies pooledImmunity forEuropean Elder
  4. Elderberry Supplementation Reduces Cold Duration and Symptoms in Air-Travellers: A Randomized, Double-Blind Placebo-Controlled Clinical Trial.
    Tiralongo E; Wee SS; Lea RA · Nutrients · 2016
    Randomized trial312 participantsImmunity forEuropean Elder
  5. Randomized study of the efficacy and safety of oral elderberry extract in the treatment of influenza A and B virus infections
    Z Zakay-Rones, E Thom, T Wollan, J Wadstein · Journal of International Medical Research · 2004
    Randomized trial60 participantsImmunity forEuropean Elder